All In MedTech

Device Trial Radar · NCT07884591

Powered Exoskeleton-Assisted Walking in Persons With Spinal Cord Injury

Multicenter Retrospective Observational Study on Gait Training With a Powered Overground Exoskeleton in Persons With Spinal Cord Injury

Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

74

Actual

Start

Sep 1, 2024

Primary completion

May 15, 2025

Study completion May 15, 2026

Sponsor

Lead sponsor
IRCCS San Raffaele RomaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 20, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Spinal Cord Injury (SCI) represents a significant health challenge, particularly when it comes to the ability to walk. Among its many consequences, mobility impairment can not only directly impact quality of life but also cause a series of secondary problems, such as urinary tract problems, breathing difficulties, muscle contractures, joint stiffness, and resulting pain. These effects can manifest early, even at a young age, further increasing the physical and psychological burden of those affected. To address these challenges, the use of overground exoskeletons, such as the Ekso Bionics (USA), has attracted growing interest in both scientific research and clinical practice. The Ekso not only offers mobility but also represents a valuable resource for gait training, with potential direct and indirect benefits for the physical health and overall well-being of people with SCI. This study is a multicenter, retrospective, pre-post cohort study with the aim of evaluating the dose-dependent effects of exoskeleton-assisted walking training on level ground on spasticity and functional independence in individuals with spinal cord injury. The sample includes at least 70 participants with SCI underwed at least five sessions of walking training using the Ekso™ exoskeleton. Primary outcomes included changes in spasticity, measured by the aggregated Modified Ashworth Scale (MAS), and functional independence, assessed by the Spinal Cord Independence Measure (SCIM) III. The ultimate aim is therefore to evaluate whether ground-based exoskeleton-assisted gait training effectively reduces spasticity and improves functional independence in individuals with spinal cord injury, as this can support the integration of wearable motorized exoskeleons into standard spinal cord injury rehabilitation protocols.

Conditions

  • Spinal Cord Injuries (SCI)
  • Muscle Spasticity as a Result of Spinal Cord Injury
  • Rehabilitation
  • Exoskeleton Device

Interventions

  • Wearable Powered ExoskeletonDevice

    Participants underwent overground gait training using the EksoGT™ wearable powered exoskeleton (Ekso Bionics, Richmond, CA, USA) as part of a multidisciplinary rehabilitation program. Exoskeleton-assisted gait training sessions were conducted under therapist supervision three times per week, with each session lasting approximately 60 minutes. The device was individually fitted and calibrated according to participant anthropometric characteristics and motor abilities. Training progression included Bilateral Max Assist mode, Adaptive mode, and ProStep+ mode, allowing a gradual transition from full robotic assistance to active user-initiated stepping. The intervention provided repetitive, task-specific overground gait practice and progressive engagement in voluntary stepping to promote motor learning, neuromuscular adaptation, and functional gait training in individuals with spinal cord injury.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Modified Ashworth Scale (MAS)Time frame: Baseline (day 1) and at the end of the 15th gait training sesssion (after 5 weeks from the day 1).

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • IRCCS San Raffaele

    Roma, Italy, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.